TRDA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Entrada Therapeutics Inc (TRDA).


$646.99M Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

TRDA Market Cap. (MRY)


TRDA Shares Outstanding (MRY)


TRDA Assets (MRY)


Total Assets

$526.32M

Total Liabilities

$97.64M

Total Investments

$318.79M

TRDA Income (MRY)


Revenue

$210.78M

Net Income

$65.63M

Operating Expense

$163.77M

TRDA Cash Flow (MRY)


CF Operations

-$41.56M

CF Investing

-$27.80M

CF Financing

$102.96M

TRDA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

TRDA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$526,321,000 (12.18%)

$469,192,000 (86.15%)

$252,056,000 (-17.58%)

$305,833,000 (602.63%)

Assets Current

$440,039,000 (19.00%)

$369,771,000 (76.19%)

$209,875,000 (-29.74%)

$298,700,000 (647.70%)

Assets Non-Current

$86,282,000 (-13.22%)

$99,421,000 (135.70%)

$42,181,000 (491.35%)

$7,133,000 (99.36%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$428,678,000 (76.88%)

$242,360,000 (14.02%)

$212,554,000 (-28.84%)

$298,718,000 (819.98%)

Property Plant & Equipment Net

$82,048,000 (-11.47%)

$92,681,000 (180.67%)

$33,021,000 (427.41%)

$6,261,000 (106.16%)

Cash & Equivalents

$105,161,000 (46.97%)

$71,552,000 (45.71%)

$49,107,000 (-83.13%)

$291,064,000 (645.46%)

Accumulated Other Comprehensive Income

-$43,000 (-122.05%)

$195,000 (109.48%)

-$2,057,000 (0%)

$0 (0%)

Deferred Revenue

$20,167,000 (-85.59%)

$139,976,000 (0%)

$0 (0%)

$0 (0%)

Total Investments

$318,787,000 (12.10%)

$284,367,000 (98.09%)

$143,555,000 (0%)

$0 (0%)

Investments Current

$318,787,000 (12.10%)

$284,367,000 (98.09%)

$143,555,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,680,000 (-37.39%)

$5,878,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,259,000 (29.97%)

$3,277,000 (-45.29%)

$5,990,000 (748.44%)

$706,000 (-55.93%)

Accumulated Retained Earnings (Deficit)

-$129,344,000 (33.66%)

-$194,970,000 (-3.55%)

-$188,285,000 (-101.01%)

-$93,669,000 (-120.34%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$667,000 (-83.42%)

$4,024,000 (0%)

$0 (0%)

$0 (0%)

Total Debt

$59,207,000 (-13.22%)

$68,230,000 (163.07%)

$25,936,000 (0%)

$0 (0%)

Debt Current

$7,559,000 (-4.43%)

$7,909,000 (-5.91%)

$8,406,000 (0%)

$0 (0%)

Debt Non-Current

$51,648,000 (-14.38%)

$60,321,000 (244.10%)

$17,530,000 (0%)

$0 (0%)

Total Liabilities

$97,643,000 (-56.95%)

$226,832,000 (474.23%)

$39,502,000 (455.19%)

$7,115,000 (111.82%)

Liabilities Current

$39,482,000 (-75.14%)

$158,796,000 (622.72%)

$21,972,000 (227.01%)

$6,719,000 (100.03%)

Liabilities Non-Current

$58,161,000 (-14.51%)

$68,036,000 (288.11%)

$17,530,000 (4326.77%)

$396,000 (0%)

TRDA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$210,782,000 (63.38%)

$129,013,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$38,465,000 (19.12%)

$32,291,000 (5.39%)

$30,639,000 (101.56%)

$15,201,000 (173.15%)

Research & Development Expense

$125,306,000 (25.45%)

$99,884,000 (49.96%)

$66,609,000 (85.41%)

$35,926,000 (70.25%)

Operating Expenses

$163,771,000 (23.90%)

$132,175,000 (35.92%)

$97,248,000 (90.21%)

$51,127,000 (91.72%)

Interest Expense

$0 (0%)

$0 (0%)

$2,632,000 (8590.32%)

-$31,000 (-121.53%)

Income Tax Expense

$859,000 (-95.42%)

$18,741,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$65,626,000 (1081.69%)

-$6,685,000 (92.93%)

-$94,616,000 (-84.95%)

-$51,158,000 (-92.88%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$65,626,000 (1081.69%)

-$6,685,000 (92.93%)

-$94,616,000 (-84.95%)

-$51,158,000 (-92.88%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$65,626,000 (1081.69%)

-$6,685,000 (92.93%)

-$94,616,000 (-84.95%)

-$51,158,000 (-92.88%)

Weighted Average Shares

$37,306,363 (12.88%)

$33,050,319 (5.61%)

$31,293,312 (399.27%)

$6,267,776 (467.09%)

Weighted Average Shares Diluted

$39,003,169 (18.01%)

$33,050,319 (5.61%)

$31,293,312 (399.27%)

$6,267,776 (467.09%)

Earning Before Interest & Taxes (EBIT)

$66,485,000 (451.47%)

$12,056,000 (113.11%)

-$91,984,000 (-79.69%)

-$51,189,000 (-94.05%)

Gross Profit

$210,782,000 (63.38%)

$129,013,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

$47,011,000 (1586.75%)

-$3,162,000 (96.75%)

-$97,248,000 (-90.21%)

-$51,127,000 (-91.72%)

TRDA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$27,798,000 (79.91%)

-$138,395,000 (6.90%)

-$148,650,000 (-3145.63%)

-$4,580,000 (-97.58%)

Net Cash Flow from Financing

$102,964,000 (389.44%)

$21,037,000 (4291.86%)

$479,000 (-99.84%)

$307,461,000 (513.83%)

Net Cash Flow from Operations

-$41,557,000 (-129.73%)

$139,803,000 (249.07%)

-$93,786,000 (-84.39%)

-$50,862,000 (-98.91%)

Net Cash Flow / Change in Cash & Cash Equivalents

$33,609,000 (49.74%)

$22,445,000 (109.28%)

-$241,957,000 (-196.01%)

$252,019,000 (1035.17%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$24,640,000 (81.44%)

-$132,781,000 (8.91%)

-$145,763,000 (0%)

$0 (0%)

Capital Expenditure

-$3,158,000 (43.75%)

-$5,614,000 (-94.46%)

-$2,887,000 (36.97%)

-$4,580,000 (-97.58%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$102,964,000 (389.44%)

$21,037,000 (4291.86%)

$479,000 (-99.75%)

$191,630,000 (77483.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$17,915,000 (36.64%)

$13,111,000 (32.50%)

$9,895,000 (291.73%)

$2,526,000 (677.23%)

Depreciation Amortization & Accretion

$3,773,000 (32.81%)

$2,841,000 (49.92%)

$1,895,000 (69.65%)

$1,117,000 (242.64%)

TRDA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00%

-

-

Profit Margin

31.10% (698.08%)

-5.20%

-

-

EBITDA Margin

33.30% (189.57%)

11.50%

-

-

Return on Average Equity (ROAE)

16.90% (682.76%)

-2.90% (92.51%)

-38.70% (2.76%)

-39.80% (-142.75%)

Return on Average Assets (ROAA)

12.10% (964.29%)

-1.40% (95.78%)

-33.20% (-13.31%)

-29.30% (65.89%)

Return on Sales (ROS)

31.50% (238.71%)

9.30%

-

-

Return on Invested Capital (ROIC)

16.60% (286.05%)

4.30% (110.39%)

-41.40% (96.29%)

-1116.10% (87.39%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

9.82 (113.02%)

-75.45 (-1585.28%)

-4.48 (-113.39%)

-2.1

Price to Sales Ratio (P/S)

3.06 (-20.85%)

3.87

-

-

Price to Book Ratio (P/B)

1.51 (-27.38%)

2.08 (4.00%)

2 (11.68%)

1.79

Debt to Equity Ratio (D/E)

0.23 (-75.64%)

0.94 (403.23%)

0.19 (675.00%)

0.02 (129.63%)

Earnings Per Share (EPS)

1.76 (980.00%)

-0.2 (93.38%)

-3.02 (62.99%)

-8.16 (66.00%)

Sales Per Share (SPS)

5.65 (44.72%)

3.9 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.2 (-129.53%)

4.06 (231.43%)

-3.09 (65.08%)

-8.85 (64.94%)

Book Value Per Share (BVPS)

11.49 (56.70%)

7.33 (7.97%)

6.79 (-85.75%)

47.66 (226.96%)

Tangible Assets Book Value Per Share (TABVPS)

14.11 (-0.62%)

14.2 (76.24%)

8.05 (-83.49%)

48.8 (23.90%)

Enterprise Value Over EBIT (EV/EBIT)

9 (-79.07%)

43 (1175.00%)

-4 (50.00%)

-8

Enterprise Value Over EBITDA (EV/EBITDA)

8.91 (-74.30%)

34.69 (890.54%)

-4.39 (46.70%)

-8.23

Asset Turnover

0.39 (44.78%)

0.27 (0%)

0 (0%)

0 (0%)

Current Ratio

11.14 (378.53%)

2.33 (-75.62%)

9.55 (-78.51%)

44.46 (273.80%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$44,715,000 (-133.32%)

$134,189,000 (238.81%)

-$96,673,000 (-74.37%)

-$55,442,000 (-98.80%)

Enterprise Value (EV)

$626,306,368 (21.20%)

$516,765,297 (30.73%)

$395,301,351 (-4.10%)

$412,192,095

Earnings Before Tax (EBT)

$66,485,000 (451.47%)

$12,056,000 (112.74%)

-$94,616,000 (-84.95%)

-$51,158,000 (-92.88%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$70,258,000 (371.63%)

$14,897,000 (116.54%)

-$90,089,000 (-79.92%)

-$50,072,000 (-92.19%)

Invested Capital

$440,885,000 (43.58%)

$307,074,000 (48.41%)

$206,913,000 (2470.35%)

$8,050,000 (616.83%)

Working Capital

$400,557,000 (89.86%)

$210,975,000 (12.28%)

$187,903,000 (-35.65%)

$291,981,000 (697.98%)

Tangible Asset Value

$526,321,000 (12.18%)

$469,192,000 (86.15%)

$252,056,000 (-17.58%)

$305,833,000 (602.63%)

Market Capitalization

$646,991,368 (28.49%)

$503,524,297 (18.58%)

$424,611,351 (-20.54%)

$534,364,095

Average Equity

$387,604,250 (67.51%)

$231,385,750 (-5.48%)

$244,801,000 (90.34%)

$128,614,000 (551.21%)

Average Assets

$543,429,500 (12.99%)

$480,944,250 (68.88%)

$284,784,500 (63.03%)

$174,680,000 (465.63%)

Invested Capital Average

$401,633,250 (44.75%)

$277,475,000 (24.99%)

$221,998,750 (4740.26%)

$4,586,500 (1439.09%)

Shares

37,419,975 (12.14%)

33,368,078 (6.25%)

31,406,165 (0.62%)

31,212,856 (10.24%)